Found 14 matching trials
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention NA As a preventive for postoperative nausea and vomiting in patients undergoin...
Show More Status
Enrolling By Invitation
Location
Samsung Medical Center
Learn More & Join Trial
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy PHASE3 Chemotherapy induced nausea and vomiting (CINV) is one of the few mostly ob...
Show More Location
Dr. BRA IRCH, AIIMS
Learn More & Join Trial
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients PHASE3 To determine the best method to prevent CINV caused by TC regimen in patien...
Show More Learn More & Join Trial
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting PHASE2 This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy PHASE2 This study evaluates the addition of fosaprepitant to currently available a...
Show More Location
SUNY Upstate Medical University
Learn More & Join Trial
Aprepitant to Improve Same Day Discharge for TKA PHASE4 The purpose of this research is to study whether adding an FDA approved med...
Show More Location
Endeavor Health Skokie Hospital
Learn More & Join Trial
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044) PHASE3 The purpose of this study is to evaluate the efficacy and safety of fosapre...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) PHASE2 The study will evaluate the efficacy and safety of aprepitant injectable em...
Show More Location
Helen Keller Hospital
Learn More & Join Trial
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting PHASE4 Nausea and vomiting are two of the more concerning adverse outcomes associa...
Show More Location
Gynecologic Oncology Associates
Learn More & Join Trial